Glucox Biotech AB
PrivateLast Round
Grant
Aug 15, 2022
Total Funding Raised
$560,000
Company Overview
Glucox Biotech AB is a biotechnology company that develops selective NOX4 inhibitors for the treatment of metabolic diseases, including type 2 diabetes, diabetic retinopathy, ischemic stroke, and acute kidney injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glucox Biotech AB Comparables
Compare Glucox Biotech AB with similar companies based on industry and business-model similarity.
Glucox Biotech AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2022 | ||||
| Early Funding | Jun 7, 2018 | ||||
| Grant | Oct 7, 2013 | ||||
| Grant | Dec 15, 2012 |
Glucox Biotech AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| European Regional Development Fund | Grant |
| Vinnova | Grant |
| SLU Holding AB | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 15, 2022
Received funding from the Eurostars SME programme.
- Jun 7, 2018
Led by Björn Sundeby with participation from Dan Hasson and Tore Bengtsson.
Glucox Biotech AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Glucox Biotech AB's valuation, stock price, and market status.
Is Glucox Biotech AB a public or private company?
Glucox Biotech AB is a private company.
What is the current stock price of Glucox Biotech AB?
Glucox Biotech AB is a private company with no public stock price. Caplight tracks Glucox Biotech AB's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Glucox Biotech AB worth (valuation)?
Valuation information for Glucox Biotech AB is not publicly available.
Can I buy Glucox Biotech AB stock?
Glucox Biotech AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Glucox Biotech AB's last funding round?
Glucox Biotech AB's most recent funding round was Grant on August 15, 2022.
Who are the main investors in Glucox Biotech AB?
Key investors in Glucox Biotech AB include Eurostars SME programme, European Regional Development Fund, Vinnova, SLU Holding AB.
Will Glucox Biotech AB IPO soon?
No public IPO plans have been announced for Glucox Biotech AB.
How can I track Glucox Biotech AB secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Glucox Biotech AB's secondary market activity and sign up for updates.